Challenges and approaches to the culture of pluripotent human embryonic stem cells

Regenerative Medicine

Volumn 2, Issue 3, 2007, Pages 265-273

  Skottman, Heli ^a   Narkilahti, Susanna ^a   Hovatta, Outi ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell culture; Embryonic stem cell; Human; Optimization

Indexed keywords

ACTIVIN A; BASIC FIBROBLAST GROWTH FACTOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HYALURONIC ACID; KERATINOCYTE GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; MATRIGEL; NICOTINAMIDE; NOGGIN; PRONASE; TRANSFORMING GROWTH FACTOR BETA;

BIOTECHNOLOGICAL PROCEDURES; BLASTOCYST; BLASTOMERE; BONE MARROW CELL; CELL ISOLATION; CELL POPULATION; CHROMOSOMAL INSTABILITY; CPG ISLAND; CULTURE MEDIUM; CULTURE TECHNIQUE; DERIVATIZATION; DNA METHYLATION; EMBRYONIC STEM CELL; ENDOMETRIUM CELL; FIBROBLAST CULTURE; GOOD MANUFACTURING PRACTICE; HUMAN; INNER CELL MASS; MORULA; MUSCLE CELL; NONHUMAN; PLACENTA; PLURIPOTENT STEM CELL; PREPUCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; SKIN CELL; ZONA PELLUCIDA;

CELL CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS;

EID: 34249777241     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.3.265     Document Type: Review

References (74)

1. Thomson JA, J Itskovitz-Eldor, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
2. Hoffman LM, Carpenter MK: Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699-708 (2005).
3. Edwards RG: IVF and the history of stem cells. Nature 413, 349-351 (2001).
4. Keller G, Snodgrass HR: Human embryonic stem cells: the future is now. Nat. Med. 5, 151-152 (1999).
5. Vallier L, Rugg-Gunn PJ, Bouhon IA, Andersson FK, Sadler AJ, Pedersen RA: Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22, 2-11 (2004).
6. Zwaka TP, Thomson JA: Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319-321 (2003).
7. Healy L, Hunt C, Young L, Stacey G: The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines. Adv. Drug Deliv. Rev. 57, 1981-1988 (2005).
8. Martin MJ, Muotri A, Gage F, Varki A: Human embryonic stem cells express an Immunigenic nonhuman stalic acid. Nat. Med. 11, 1-5 (2005).
9. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000).
10. Guhr A, Kurtz A, Friedgen K, Loser P: Current state of human embryonic stem cell research: an overview of cell lines and their usage in experimental work. Stem Cells (2006).
11. Genbacev O, Krtolica A, Zdravkovic T et al.: Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil. Steril. 83, 1517-1529 (2005).
12. Tanaka N, Takeuchi T, Neri QV, Sills ES, Palermo GD: Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model. J. Transl. Med. 4, 20 (2006).
13. Heins N, Englund MC, Sjoblom C et al.: Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22, 367-376 (2004).
14. Strelchenko N, Verlinsky O, Kukharenko V, Verlinsky Y: Morula-derived human embryonic stem cells. Reprod. Biomed. Online 9, 623-629 (2004).
15. Zhang X, Stojkovic P, Przyborski S et al.: Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24, 2669-2676 (2006).
16. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R: Human embryonic stem cell lines derived from single blastomeres. Nature 444, 481-485 (2006).
17. Fong CY, Richards M, Bongso A. Unsuccessful derivation of human embryonic stem cell lines from pairs of human blastomeres. Reproduction Biomed Online 13, 295-300 (2006).
18. Cole R, Edwards R, Paul J: Cytodifferentiation in cell colonies and cell strains derived from cleaving ova and blastocysts of the rabbit. Exp. Cells Res. 37, 501-504 (1964).
19. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
20. Martin GR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (1981).
21. Amit M, Margulets V, Segev H et al.: Human feeder layers for human embryonic stem cells. Biol. Reprod. 68, 2150-2156 (2003).
22. Hovatta O, Mikkola M, Gertow K et al.: A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum. Reprod. 18, 1404-1409 (2003).
23. Lee JB. Lee JE, Park JH et al.: Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol. Reprod. 72, 42-49 (2005).
24. Cheng L, Hammond H, Ye Z, Zhan X, Dravid G: Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 21, 131-142 (2003).
25. Richards M, Fong CY, Chan WK, Wong PC, Bongso A: Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936 (2002).
26. Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A: Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 21, 546-556 (2003).
27. Stojkovic P, Lako M, Stewart R et al.: An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 23, 306-314 (2005).
28. Wang L, Li L, Menendez P, Cerdan C, Bhatia M: Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 105, 4598-4603 (2005).
29. Amit M, Carpenter MK, Inokuma MS et al.: Clonally derived human embryonic stem cell lines maintain pluripotency am proliferative potential for prolonged periods of culture. Dev Biol. 227, 271-278 (2000).
30. Koivisto H, Hyvärinen M, Strömberg A-M et al.: Cultures of human embryonic stem cells - serum replacement medium or serum-containing media and the effect of basic fibrolast growth factor. Reprod. Biomed. Online 9, 330-337 (2004).
31. Stojkovic M, Lako M, Stojkovic P et al.: Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in Vitro culture. Stem Cells 22, 790-797 (2004).
32. Amit M, Shariki C, Margulets V, J Itskovitz-Eldor: Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 70, 837-845 (2004).
33. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH: Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63 (2004).
34. Wang Q, Fang ZF, Jin F, Lu Y, Gai H, Sheng HZ: Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells 23, 1221-1227 (2005).
35. Wang G, Zhang H, Zhao Y et al.: Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem. Biophys. Res. Commun. 330, 934-942 (2005).
36. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA: Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185-190 (2005).
37. Pebay A, Wong RC, Pitson SM et al.: Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 23, 1541-1548 (2005).
38. Carpenter MK, Rosler ES. Fisk GJ et al.: Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev. Dyn. 229, 243-258 (2004).
39. Xu C, Inokuma MS, Denham J et al.: Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974 (2001).
40. Kleinman HK, McGarvey ML, Hassell JR et al.: Basement membrane complexes with biological activity. Biochemistry 25, 312-318 (1986).
41. Beattie GM, Lopez AD, Bucay N et al.: Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23, 489-495 (2005).
42. Noaksson K, Zoric N, Zeng X et al.: Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells 23, 1460-1467 (2005).
43. Stojkovic P, Lako M, Przyborski S et al.: Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23, 895-902 (2005).
44. Aghajanova L, Skottman H, Stromberg AM, Inzunza J, Lahesmaa R, Hovatta O: Expression of leukemia inhibitory factor and its receptors is increased during differentiation of human embryonic stem cells. Fertil. Steril. 86(Suppl. 4), 1193-1209 (2006).
45. Lim JW, Bodnar A: Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2, 1187-1203 (2002).
46. Xiao L, Yuan X, Sharkis SJ: Activin A maintains self-renewal and regulates FGF, Wnt and BMP pathways in human embryonic stem cells. Stem Cells 4, 1476-1486 (2006).
47. Liu Y, Song Z, Zhao Y et al.: A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem. Biophys. Res. Commun. 346, 131-139 (2006).
48. Vallier L, Alexander M, Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509 (2005).
49. Yao S, Chen S, Clark J et al.: Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl Acad. Sci. USA 103, 6907-6912 (2006).
50. Li Y, Powell S, Brunette E, Lebkowski J. Mandalam R: Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 91, 688-698 (2005).
51. Lu J, Hou R, Booth CJ, Yang SH, Snyder M: Defined culture conditions of human embryonic stem cells. Proc. Natl Acad. Sci. USA 103, 5688-5693 (2006).
52. Ludwig T, Levenstein M, Jones J et al.: Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187 (2006).
53. Draper JS, Smith K, Gokhale P et al.: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22, 53-54 (2004).
54. Klimanskaya I, Chung Y, Meisner L, Johnson J, West M, Lanza R: Human embryonic stem cells derived without feeder cells. Lancet 365, 1636-1641 (2005).
55. Andrews PW, Benvenisty N, McKay R et al.: The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nat. Biotechnol. 23, 795-797 (2005).
56. Smith AG: Embryo-derived stem cells: of mice and men. Ann. Rev. Cell Dev. Biol. 17, 435-462 (2001).
57. Rodriguez CI, Galan A, Valbuena D, Simon C: Derivation of clinical-grade human embryonic stem cells. Reprod. Biomed. Online 12, 112-118 (2006).
58. Cowan CA, Klimanskaya I, McMahon J et al.: Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356 (2004).
59. Inzunza J, Sahlen S, Holmberg K et al.: Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after longterm cultivation. Mol. Hum. Reprod. 10, 461-466 (2004).
60. Rosler ES, Fisk GJ, Ares X et al.: Longterm culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259-274 (2004).
61. Maitra A, Arking DE, Shivapurkar N et al.: Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099-1103 (2005).
62. Mitalipova MM, Rao RR, Hoyer DM et al.: Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20 (2005).
63. Shen Y, Chow J, Wang Z, Fan G: Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum. Mol. Genet. 15, 2623-2635 (2006).
64. Zuck T: Current good manufacturing practices. Transfusion 35, 955-966 (1995).
65. Lanzendorf SE, Boyd CA, Wright DL, Muasher S. Oehninger S, Hodgen GD: Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil. Steril. 76, 132-137 (2001).
66. Pickering SJ, Braude PR, Patel M et al.: Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod. Biomed. Online 7, 353-364 (2003).
67. Mitalipova M, Calhoun J, Shin S et al.: Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21, 521-526 (2003).
68. Oh SK, Kim HS, Ahn HJ et al.: Derivation and characterization of new human embryonic stem cell lines: SNUhES1, SNUhES2, and SNUhES3. Stem Cells 23, 211-219 (2005).
69. Chen H, Qian K, Hu J et al.: The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. Hum. Reprod. 20, 2201-2206 (2005).
70. Inzunza J, Gertow K, Stromberg MA et al.: Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23, 544-549 (2005).
71. Kim H, Oh S, Park Y et al.: Methods for derivation of human embryonic stem cells. Stem Cells 23, 1228-1233 (2005).
72. Hong-mei P, Gui-an C: Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum. Reprod. 21, 217-222 (2006).
73. Mateizel I, De Temmerman N, Ullmann U et al.: Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod. 21, 503-511 (2006).
74. Zhang X, Stojkovic P, Przyborski S et al.: Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24, 2669-2676 (2006).